Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Thyroid Carcinoma, Anaplastic × Fluorodeoxyglucose F18 × 1 year × Clear all

Sponsor

Conditions

Breast Neoplasms 15 Stomach Neoplasms 5 Carcinoma, Transitional Cell 5 Uterine Cervical Neoplasms 4 Sarcoma 4 Prostatic Neoplasms 4 Ovarian Neoplasms 4 Multiple Myeloma 4 Lung Neoplasms 4 Esophageal Neoplasms 4 Carcinoma, Hepatocellular 4 Urinary Bladder Neoplasms 3 Thyroid Neoplasms 3 Neuroendocrine Tumors 3 Neoplasms 3 Cholangiocarcinoma 3 Anus Neoplasms 3 Testicular Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Solid Tumor 2 Pheochromocytoma 2 Paraganglioma 2 Pancreatic Neoplasms 2 Oropharyngeal Neoplasms 2 Neoplasm Metastasis 2 Mouth Neoplasms 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma, B-Cell, Marginal Zone 2 Hodgkin Disease 2 Carcinoma, Renal Cell 2

Interventions

trametinib 5 dabrafenib 5 pembrolizumab 2 cobimetinib 2 atezolizumab 2 Vemurafenib 2 Radiotherapy, Intensity-Modulated 2 Paclitaxel 2 zimberelimab 1 tislelizumab 1 surufatinib 1 selpercatinib 1 lenvatinib 1 fludarabine 1 cemiplimab 1 cabozantinib 1 aldesleukin 1 abemaciclib 1 Taxes 1 Nivolumab 1 Ipilimumab 1 Immunoglobulin G 1 Disulfides 1 Cyclophosphamide 1 CTLA-4 Antigen 1 Bevacizumab 1 Albumin-Bound Paclitaxel 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡